Radius Health (RDUS) Misses Q2 EPS by 17c

Radius Health (NASDAQ: RDUS) reported Q2 EPS of ($1.52), $0.17 worse than the analyst estimate of ($1.35). Revenue for the quarter came in at $22.63 million versus the consensus estimate of $20.46 million.

For earnings history and earnings-related data on Radius Health (RDUS) click here.

You May Also Be Interested In

• SK Hynix vs. Micron deep dive: who wins the AI memory supercycle?
• Benchmark Reiterates Buy Rating on Tower Semiconductor (TSEM) Following Japan Capacity Announcement
• Morgan Stanley shares gain as equities trading, dealmaking fuel Q2 earnings beat